Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data

Author： Standaert B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.10, 2002-01, pp. : 665-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Filgrastim/lenograstim: Acute myeloid leukaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

In elderly patients with poor-prognosis acute myeloid leukaemia (AML), filgrastim may be a beneficial adjunct to supportive care

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program

By Ridyard Colin H.   Hughes Dyfrig A.  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 867-872

Blackwell Publishing

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Gemtuzumab Ozogamicin: A Review of its Use in Acute Myeloid Leukaemia

By Fenton Caroline   Perry Caroline M.  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2405-2427

Adis International

Access to resources Recommend Favorite